Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Net Income: 2012-2024

Historic Net Income for Sunshine Biopharma (SBFM) over the last 11 years, with Dec 2024 value amounting to -$5.1 million.

  • Sunshine Biopharma's Net Income rose 26.21% to -$883,820 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.0 million, marking a year-over-year decrease of 41.81%. This contributed to the annual value of -$5.1 million for FY2024, which is 13.94% down from last year.
  • As of FY2024, Sunshine Biopharma's Net Income stood at -$5.1 million, which was down 13.94% from -$4.5 million recorded in FY2023.
  • Sunshine Biopharma's Net Income's 5-year high stood at -$2.8 million during FY2020, with a 5-year trough of -$26.7 million in FY2022.
  • For the 3-year period, Sunshine Biopharma's Net Income averaged around -$12.1 million, with its median value being -$5.1 million (2024).
  • Per our database at Business Quant, Sunshine Biopharma's Net Income crashed by 378.17% in 2020 and then skyrocketed by 83.15% in 2023.
  • Yearly analysis of 5 years shows Sunshine Biopharma's Net Income stood at -$2.8 million in 2020, then slumped by 346.70% to -$12.4 million in 2021, then slumped by 115.05% to -$26.7 million in 2022, then surged by 83.15% to -$4.5 million in 2023, then dropped by 13.94% to -$5.1 million in 2024.